METZGER MICHAEL A (President and COO) sold 3.4% of their position (17.16K shares) of SYNDAX PHARMACEUTICALS INC on the open market
Open‑market sale worth $360.8K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 2/10/2026ACC: 0001193125-26-043814
Officer· President and COO
Since Feb 2019
-17.16K
Net shares
Net seller
$360.8K
Total sold
1
Open market trades
0B · 1S
1
Total transactions
17.16K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−17.16K
Price / share
$21.03
Trade value
$360.82K
% of position
3.4%
2/9/2026
508.85K→491.69K
Total
Net shares
−17.16K
Net value
-$360.82K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 2/9/2026 | S · Sale | −17.16K | $21.03 | $360.82K | 3.4% | 508.85K | 491.69K |
| Total | −17.16K | -$360.82K | ||||||
Derivative Transactions0
No derivative transactions reported